Alison R. Buick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alison R. Buick has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Richard G. Carson
Trinity College Institute of Neuroscience and School of Psychology Trinity College Dublin Dublin Ireland
5 shared publications - Eileen Furlong
School of Nursing, Midwifery and Health Systems University College Dublin Dublin Ireland
3 shared publications - Grigorios Kotronoulas
School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK
3 shared publications - Jo Armes
School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK
3 shared publications - Paul McCrone
Institute for Lifecourse Development, University of Greenwich, London, UK
3 shared publications - Roma Maguire
University of Strathclyde, Glasgow, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S15)
Feasibility of real world end‐points of functional neurophysiology in Alzheimer’s disease dementia
Background: Clinic‐based biomarkers are effective in tracking disease progression in clinical research, but do not scale to support public health needs or large‐scale real‐world studies. Purely digital markers are scalable but lack the objectivity and neurobiological grounding of clinical measures. These first results of a real‐world feasibility study demonstrate that objective measures of a range of domains including EEG (Figure 1) are user‐friendly and suitable for repeated at‐home use by patients and older controls.Method: 60 patients and 60 matched controls are being recruited for a 1‐year repeated sampling study in the UK. Patients were clinically assessed to have mild Alzheimer’s type dementia. Participants were asked to complete about 30 minutes of behavioral tasks including memory, executive function, affective processing and language, while synchronized EEG was recorded using a self‐applied dry‐sensor headset. This interim data is from an initial 2‐week burst sampling period, for the first half of the cohorts.Result: Adherence was 76% for the dementia group (N = 29, mean age = 75; ADAS = Cog 24.3) and 88% for the control group (N = 36, mean age = 71; ADAS = Cog 7.8). A symbol substitution task (executive function) differentiated strongly between groups (t(53) = 6.9), and correlated highly with a conventional pen‐and‐paper DSST benchmark (rho = 0.79). An associative memory task also patterned strongly with disease status (t(54) = 5.7) and correlated with the Verbal Paired Associates benchmark (rho = 0.76). The grand average P300 ERP, elicited by a gamified 2‐stimulus oddball task, showed characteristic features of sensory and higher cognitive processing (Figure 2). As expected in the patient group, the P300 was reduced and delayed; and the resting‐state EEG theta and alpha power were enhanced and reduced, respectively. Radar plots (Figure 3), illustrate the pattern observed across domains in one representative Alzheimer’s patient and one control. Data from a fronto‐temporal dementia sister study is included for comparison.Conclusion: Interim data from this first‐in‐class study suggest that patients with mild Alzheimer’s disease dementia are capable and willing to participate in intensive home‐based functional neurophysiology studies, if technology is designed to be engaging and easy to use. Initial examination of the data aligns with established benchmarks, constituting positive early evidence for construct validity and technical feasibility.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S15)
Open AccessFeasibility of real world end‐points of functional neurophysiology in Alzheimer’s disease dementia
Background: Clinic‐based biomarkers are effective in tracking disease progression in clinical research, but do not scale to support public health needs or large‐scale real‐world studies. Purely digital markers are scalable but lack the objectivity and neurobiological grounding of clinical measures. These first results of a real‐world feasibility study demonstrate that objective measures of a range of domains including EEG (Figure 1) are user‐friendly and suitable for repeated at‐home use by patients and older controls.Method: 60 patients and 60 matched controls are being recruited for a 1‐year repeated sampling study in the UK. Patients were clinically assessed to have mild Alzheimer’s type dementia. Participants were asked to complete about 30 minutes of behavioral tasks including memory, executive function, affective processing and language, while synchronized EEG was recorded using a self‐applied dry‐sensor headset. This interim data is from an initial 2‐week burst sampling period, for the first half of the cohorts.Result: Adherence was 76% for the dementia group (N = 29, mean age = 75; ADAS = Cog 24.3) and 88% for the control group (N = 36, mean age = 71; ADAS = Cog 7.8). A symbol substitution task (executive function) differentiated strongly between groups (t(53) = 6.9), and correlated highly with a conventional pen‐and‐paper DSST benchmark (rho = 0.79). An associative memory task also patterned strongly with disease status (t(54) = 5.7) and correlated with the Verbal Paired Associates benchmark (rho = 0.76). The grand average P300 ERP, elicited by a gamified 2‐stimulus oddball task, showed characteristic features of sensory and higher cognitive processing (Figure 2). As expected in the patient group, the P300 was reduced and delayed; and the resting‐state EEG theta and alpha power were enhanced and reduced, respectively. Radar plots (Figure 3), illustrate the pattern observed across domains in one representative Alzheimer’s patient and one control. Data from a fronto‐temporal dementia sister study is included for comparison.Conclusion: Interim data from this first‐in‐class study suggest that patients with mild Alzheimer’s disease dementia are capable and willing to participate in intensive home‐based functional neurophysiology studies, if technology is designed to be engaging and easy to use. Initial examination of the data aligns with established benchmarks, constituting positive early evidence for construct validity and technical feasibility.
- Open Access
- 14 March 2019
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 5 (1) , e10813
Adaptation and Implementation of a Mobile Phone–Based Remote Symptom Monitoring System for People With Cancer in Europe
Background: There has been an international shift in health care, which has seen an increasing focus and development of technological and personalized at-home interventions that aim to improve health outcomes and patient-clinician communication. However, there is a notable lack of empirical evidence describing the preparatory steps of adapting and implementing technology of this kind across multiple countries and clinical settings. Objective: This study aimed to describe the steps undertaken in the preparation of a multinational, multicenter randomized controlled trial (RCT) to test a mobile phone–based remote symptom monitoring system, that is, Advanced Symptom Management System (ASyMS), designed to enhance management of chemotherapy toxicities among people with cancer receiving adjuvant chemotherapy versus standard cancer center care. Methods: There were 13 cancer centers across 5 European countries (Austria, Greece, Ireland, Norway, and the United Kingdom). Multiple steps were undertaken, including a scoping review of empirical literature and clinical guidelines, translation and linguistic validation of study materials, development of standardized international care procedures, and the integration and evaluation of the technology within each cancer center. Results: The ASyMS was successfully implemented and deployed in clinical practices across 5 European countries. The rigorous and simultaneous steps undertaken by the research team highlighted the strengths of the system in clinical practice, as well as the clinical and technical changes required to meet the diverse needs of its intended users within each country, before the commencement of the RCT. Conclusions: Adapting and implementing this multinational, multicenter system required close attention to diverse considerations and unique challenges primarily related to communication and clinical and technical issues. Success was dependent on collaborative and transparent communication among academics, the technology industry, translation partners, patients, and clinicians as well as a simultaneous and rigorous methodological approach within the 5 relevant countries.
- 14 March 2019
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 5 (1) , e10813
Open AccessAdaptation and Implementation of a Mobile Phone–Based Remote Symptom Monitoring System for People With Cancer in Europe
Background: There has been an international shift in health care, which has seen an increasing focus and development of technological and personalized at-home interventions that aim to improve health outcomes and patient-clinician communication. However, there is a notable lack of empirical evidence describing the preparatory steps of adapting and implementing technology of this kind across multiple countries and clinical settings. Objective: This study aimed to describe the steps undertaken in the preparation of a multinational, multicenter randomized controlled trial (RCT) to test a mobile phone–based remote symptom monitoring system, that is, Advanced Symptom Management System (ASyMS), designed to enhance management of chemotherapy toxicities among people with cancer receiving adjuvant chemotherapy versus standard cancer center care. Methods: There were 13 cancer centers across 5 European countries (Austria, Greece, Ireland, Norway, and the United Kingdom). Multiple steps were undertaken, including a scoping review of empirical literature and clinical guidelines, translation and linguistic validation of study materials, development of standardized international care procedures, and the integration and evaluation of the technology within each cancer center. Results: The ASyMS was successfully implemented and deployed in clinical practices across 5 European countries. The rigorous and simultaneous steps undertaken by the research team highlighted the strengths of the system in clinical practice, as well as the clinical and technical changes required to meet the diverse needs of its intended users within each country, before the commencement of the RCT. Conclusions: Adapting and implementing this multinational, multicenter system required close attention to diverse considerations and unique challenges primarily related to communication and clinical and technical issues. Success was dependent on collaborative and transparent communication among academics, the technology industry, translation partners, patients, and clinicians as well as a simultaneous and rigorous methodological approach within the 5 relevant countries.
- Open Access
- 13 February 2019
- Published by Springer Nature in Experimental Brain Research
- Vol. 237 (4) , 1077-1092
Interlimb transfer and generalisation of learning in the context of persistent failure to accomplish a visuomotor task
Transfer, in which capability acquired in one situation influences performance in another is considered, along with retention, as demonstrative of effectual learning. In this regard, interlimb transfer of functional capacity has commanded particular attention as a means of gauging the generalisation of acquired capability. Both theoretical treatments and prior empirical studies suggest that the successful accomplishment of a physical training regime is required to bring about generalised changes that extend to the untrained limb. In the present study, we pose the following question: Does interlimb transfer occur if and only if the training movements are executed? We report findings from JG—an individual recruited to a larger scale trial, who presented with (unilateral) deficits of motor control. We examined whether changes in the performance of the untrained right limb arose following practice undertaken by the impaired left limb, wherein the majority of JG’s attempts to execute the training task were unsuccessful. Comparison was made with a group of “control” participants drawn from the main trial, who did not practice the task. For JG, substantial gains in the performance of the untrained limb (registered 3 days, 10 days and 1 year following training) indicated that effective learning had occurred. Learning was, however, expressed principally when the unimpaired (i.e. untrained) limb was utilised to perform the task. When the impaired limb was used, marked deficiencies in movement execution remained prominent throughout.
- 13 February 2019
- Published by Springer Nature in Experimental Brain Research
- Vol. 237 (4) , 1077-1092
Open AccessInterlimb transfer and generalisation of learning in the context of persistent failure to accomplish a visuomotor task
Transfer, in which capability acquired in one situation influences performance in another is considered, along with retention, as demonstrative of effectual learning. In this regard, interlimb transfer of functional capacity has commanded particular attention as a means of gauging the generalisation of acquired capability. Both theoretical treatments and prior empirical studies suggest that the successful accomplishment of a physical training regime is required to bring about generalised changes that extend to the untrained limb. In the present study, we pose the following question: Does interlimb transfer occur if and only if the training movements are executed? We report findings from JG—an individual recruited to a larger scale trial, who presented with (unilateral) deficits of motor control. We examined whether changes in the performance of the untrained right limb arose following practice undertaken by the impaired left limb, wherein the majority of JG’s attempts to execute the training task were unsuccessful. Comparison was made with a group of “control” participants drawn from the main trial, who did not practice the task. For JG, substantial gains in the performance of the untrained limb (registered 3 days, 10 days and 1 year following training) indicated that effective learning had occurred. Learning was, however, expressed principally when the unimpaired (i.e. untrained) limb was utilised to perform the task. When the impaired limb was used, marked deficiencies in movement execution remained prominent throughout.
- Open Access
- 18 April 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Adaptation and Implementation of a Mobile Phone–Based Remote Symptom Monitoring System for People With Cancer in Europe (Preprint)
BACKGROUND There has been an international shift in health care, which has seen an increasing focus and development of technological and personalized at-home interventions that aim to improve health outcomes and patient-clinician communication. However, there is a notable lack of empirical evidence describing the preparatory steps of adapting and implementing technology of this kind across multiple countries and clinical settings. OBJECTIVE This study aimed to describe the steps undertaken in the preparation of a multinational, multicenter randomized controlled trial (RCT) to test a mobile phone–based remote symptom monitoring system, that is, Advanced Symptom Management System (ASyMS), designed to enhance management of chemotherapy toxicities among people with cancer receiving adjuvant chemotherapy versus standard cancer center care. METHODS There were 13 cancer centers across 5 European countries (Austria, Greece, Ireland, Norway, and the United Kingdom). Multiple steps were undertaken, including a scoping review of empirical literature and clinical guidelines, translation and linguistic validation of study materials, development of standardized international care procedures, and the integration and evaluation of the technology within each cancer center. RESULTS The ASyMS was successfully implemented and deployed in clinical practices across 5 European countries. The rigorous and simultaneous steps undertaken by the research team highlighted the strengths of the system in clinical practice, as well as the clinical and technical changes required to meet the diverse needs of its intended users within each country, before the commencement of the RCT. CONCLUSIONS Adapting and implementing this multinational, multicenter system required close attention to diverse considerations and unique challenges primarily related to communication and clinical and technical issues. Success was dependent on collaborative and transparent communication among academics, the technology industry, translation partners, patients, and clinicians as well as a simultaneous and rigorous methodological approach within the 5 relevant countries.
- 18 April 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAdaptation and Implementation of a Mobile Phone–Based Remote Symptom Monitoring System for People With Cancer in Europe (Preprint)
BACKGROUND There has been an international shift in health care, which has seen an increasing focus and development of technological and personalized at-home interventions that aim to improve health outcomes and patient-clinician communication. However, there is a notable lack of empirical evidence describing the preparatory steps of adapting and implementing technology of this kind across multiple countries and clinical settings. OBJECTIVE This study aimed to describe the steps undertaken in the preparation of a multinational, multicenter randomized controlled trial (RCT) to test a mobile phone–based remote symptom monitoring system, that is, Advanced Symptom Management System (ASyMS), designed to enhance management of chemotherapy toxicities among people with cancer receiving adjuvant chemotherapy versus standard cancer center care. METHODS There were 13 cancer centers across 5 European countries (Austria, Greece, Ireland, Norway, and the United Kingdom). Multiple steps were undertaken, including a scoping review of empirical literature and clinical guidelines, translation and linguistic validation of study materials, development of standardized international care procedures, and the integration and evaluation of the technology within each cancer center. RESULTS The ASyMS was successfully implemented and deployed in clinical practices across 5 European countries. The rigorous and simultaneous steps undertaken by the research team highlighted the strengths of the system in clinical practice, as well as the clinical and technical changes required to meet the diverse needs of its intended users within each country, before the commencement of the RCT. CONCLUSIONS Adapting and implementing this multinational, multicenter system required close attention to diverse considerations and unique challenges primarily related to communication and clinical and technical issues. Success was dependent on collaborative and transparent communication among academics, the technology industry, translation partners, patients, and clinicians as well as a simultaneous and rigorous methodological approach within the 5 relevant countries.
- Open Access
The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer
Introduction While some evidence exists that real-time remote symptom monitoring devices can decrease morbidity and prevent unplanned admissions in oncology patients, overall, these studies have significant methodological weaknesses. The electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology (eSMART) study is designed to specifically address these weaknesses with an appropriately powered, repeated-measures, parallel-group stratified randomised controlled trial of oncology patients. Methods and analysis A total of 1108 patients scheduled to commence first-line chemotherapy (CTX) for breast, colorectal or haematological cancer will be recruited from multiple sites across five European countries. Patients will be randomised (1:1) to the ASyMS intervention (intervention group) or to standard care currently available at each site (control group). Patients in the control and intervention groups will complete a demographic and clinical questionnaire, as well as a set of valid and reliable electronic patient-reported outcome measures at enrolment, after each of their CTX cycles (up to a maximum of six cycles) and at 3, 6, 9 and 12 months after completion of their sixth cycle of CTX. Outcomes that will be assessed include symptom burden (primary outcome), quality of life, supportive care needs, anxiety, self-care self-efficacy, work limitations and cost effectiveness and, from a health professional perspective, changes in clinical practice (secondary outcomes). Ethics and dissemination Ethical approval will be obtained prior to the implementation of all major study amendments. Applications will be submitted to all of the ethics committees that granted initial approval. eSMART received approval from the relevant ethics committees at all of the clinical sites across the five participating countries. In collaboration with the European Cancer Patient Coalition (ECPC), the trial results will be disseminated through publications in scientific journals, presentations at international conferences, and postings on the eSMART website and other relevant clinician and consumer websites; establishment of an eSMART website (www.esmartproject.eu) with publicly accessible general information; creation of an eSMART Twitter Handle, and production of a toolkit for implementing/utilising the ASyMS technology in a variety of clinical practices and other transferable health care contexts. Trial registration number NCT02356081.
Open AccessThe eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer
Introduction While some evidence exists that real-time remote symptom monitoring devices can decrease morbidity and prevent unplanned admissions in oncology patients, overall, these studies have significant methodological weaknesses. The electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology (eSMART) study is designed to specifically address these weaknesses with an appropriately powered, repeated-measures, parallel-group stratified randomised controlled trial of oncology patients. Methods and analysis A total of 1108 patients scheduled to commence first-line chemotherapy (CTX) for breast, colorectal or haematological cancer will be recruited from multiple sites across five European countries. Patients will be randomised (1:1) to the ASyMS intervention (intervention group) or to standard care currently available at each site (control group). Patients in the control and intervention groups will complete a demographic and clinical questionnaire, as well as a set of valid and reliable electronic patient-reported outcome measures at enrolment, after each of their CTX cycles (up to a maximum of six cycles) and at 3, 6, 9 and 12 months after completion of their sixth cycle of CTX. Outcomes that will be assessed include symptom burden (primary outcome), quality of life, supportive care needs, anxiety, self-care self-efficacy, work limitations and cost effectiveness and, from a health professional perspective, changes in clinical practice (secondary outcomes). Ethics and dissemination Ethical approval will be obtained prior to the implementation of all major study amendments. Applications will be submitted to all of the ethics committees that granted initial approval. eSMART received approval from the relevant ethics committees at all of the clinical sites across the five participating countries. In collaboration with the European Cancer Patient Coalition (ECPC), the trial results will be disseminated through publications in scientific journals, presentations at international conferences, and postings on the eSMART website and other relevant clinician and consumer websites; establishment of an eSMART website (www.esmartproject.eu) with publicly accessible general information; creation of an eSMART Twitter Handle, and production of a toolkit for implementing/utilising the ASyMS technology in a variety of clinical practices and other transferable health care contexts. Trial registration number NCT02356081.
- 1 January 2016
- Published by Elsevier in Neuroscience Letters
- Vol. 612, 87-91
Characteristics of corticospinal projections to the intrinsic hand muscles in skilled harpists
- 1 January 2016
- Published by Elsevier in Neuroscience Letters
- Vol. 612, 87-91
Characteristics of corticospinal projections to the intrinsic hand muscles in skilled harpists
- 1 October 2015
- Published by Elsevier in Clinical Neurophysiology
- Vol. 126 (10) , 1934-1940
Interhemispheric inhibition of corticospinal projections to forearm muscles
- 1 October 2015
- Published by Elsevier in Clinical Neurophysiology
- Vol. 126 (10) , 1934-1940
Interhemispheric inhibition of corticospinal projections to forearm muscles
- 11 March 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 24 (1) , 79-87
Tele-Supervised FES-Assisted Exercise for Hemiplegic Upper Limb
Stroke survivors often have upper limb (UL) hemiparesis, limiting their ability to perform activities of daily life (ADLs). Intensive, task-oriented exercise therapy (ET) can improve UL function, but motivation to perform sufficient ET is difficult to maintain. Here, we report on a trial in which a workstation was deployed in the homes of chronic stroke survivors to enable tele-coaching of ET in the guise of computer games. Participants performed six weeks of 1 h/day, five days/week ET. Hand opening and grasp were assisted with functional electrical stimulation (FES). The primary outcome measure was the Action Research Arm Test (ARAT). Secondary outcome measures included a quantitative test of UL function performed on the workstation, grasp force measurements and transcranial magnetic stimulation (TMS). Improvements were seen in the functional tests, but surprisingly, not in the TMS responses. An important finding was that participants commencing with intermediate functional scores improved the most. Conclusions: 1) Daily, tele-supervised FES-ET in chronic stroke survivors is feasible with commercially-available technology. 2) The intervention can significantly improve UL function, particularly in people who start with an intermediate level of function. 3) Significant improvements in UL function can occur in the absence of changes in TMS responses.
- 11 March 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 24 (1) , 79-87
Tele-Supervised FES-Assisted Exercise for Hemiplegic Upper Limb
Stroke survivors often have upper limb (UL) hemiparesis, limiting their ability to perform activities of daily life (ADLs). Intensive, task-oriented exercise therapy (ET) can improve UL function, but motivation to perform sufficient ET is difficult to maintain. Here, we report on a trial in which a workstation was deployed in the homes of chronic stroke survivors to enable tele-coaching of ET in the guise of computer games. Participants performed six weeks of 1 h/day, five days/week ET. Hand opening and grasp were assisted with functional electrical stimulation (FES). The primary outcome measure was the Action Research Arm Test (ARAT). Secondary outcome measures included a quantitative test of UL function performed on the workstation, grasp force measurements and transcranial magnetic stimulation (TMS). Improvements were seen in the functional tests, but surprisingly, not in the TMS responses. An important finding was that participants commencing with intermediate functional scores improved the most. Conclusions: 1) Daily, tele-supervised FES-ET in chronic stroke survivors is feasible with commercially-available technology. 2) The intervention can significantly improve UL function, particularly in people who start with an intermediate level of function. 3) Significant improvements in UL function can occur in the absence of changes in TMS responses.
- 1 September 2013
- Published by Elsevier in Brain Stimulation
- Vol. 6 (5) , 760-768
Characterizing Changes in the Excitability of Corticospinal Projections to Proximal Muscles of the Upper Limb
- 1 September 2013
- Published by Elsevier in Brain Stimulation
- Vol. 6 (5) , 760-768
Characterizing Changes in the Excitability of Corticospinal Projections to Proximal Muscles of the Upper Limb